FAHRETA ODOBASIC: Open Payments
NPI 1770141822 · NEW HARTFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$472 in 7 payments from 6 companies in 2025. Trend: 2023 $140 · 2024 $14 · 2025 $472
Food & beverage: $472
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $132 |
| Agios Pharmaceuticals, Inc. | 1 | $125 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $116 |
| MERZ NORTH AMERICA, INC. | 1 | $49 |
| Grifols USA, LLC | 1 | $30 |
| Dexcom, Inc. | 1 | $20 |
Products named: AIRSUPRA, PYRUKYND, XIFAXAN, Xeomin, Prolastin-C Liquid, Dexcom G6 Transmitter.
Industry payments across NY — which companies pay providers there.
